MAPS Bulletin Spring 2018: Vol 28, No. 1 Special Edition: Breakthrough

Download this entire issue or browse individual articles by title below.

Front Cover
Breakthrough | Spring 2018
Back Cover
Therapy Training Quilt
 Front Cover
1Developing MDMA into a Prescription Medicine for PTSDMAPS
 Table of ContentsMAPS
2From the Desk of Rick Doblin, Ph.D., MAPS Founder and Executive DirectorRick Doblin, Ph.D.
4Research NewsMAPS
10MAPS in the MediaMAPS
12Breakthrough Therapy Designation: Streamlining the Path to ApprovalMatthew J. Neal
15How to Change Your Mind: An interview with author Michael Pollan
Brad Burge
18MAPS-Sponsored Research at the 2017 Annual Meeting of the International Society for Traumatic Stress Studies: Signs of Breaking Through ResistanceMichael Mithoefer, M.D.
22From Print to Presentations: The Importance of Communicating Findings from Psychedelic and Cannabis StudiesIlsa Jerome, Ph.D., & Allison Feduccia, Ph.D.
25Clinical Supervision in MDMA Therapy Training: An Ethical CommitmentShannon Clare Carlin, M.A.
27The Right to Science and Freedom of Research with Scheduled Substances: MAPS at the United Nations 61st Commission on Narcotic DrugsNatalie Lyla Ginsberg, M.S.W.
30From the Personal to the Political: Why Psychedelic Therapy is a Bipartisan IssueSGT(R) Jonathan M Lubecky
32I Tried MDMA-Assisted Therapy, and I Still Have PTSD: Here’s What I Think About ItKristina Cizmar Eklund
35Cryptocurrency Philanthropy Catapults Fundraising for Phase 3 TrialsMAPS
39The Zendo Project: Evolving Psychedelic Support Since 2012Ryan Beauregard
42Psychedelic Integration Through Community Service: My Experience Starting a Psychedelic SocietyKwasi Adusei
44The Beckley Foundation Brings Microdosing Under the MicroscopeAmanda Feilding
47Black Masks, Rainbow Bodies: Psychedelics and RaceNicholas Powers
52Breaking on Through: The Psychedelic Experience 50 Years LaterJohn Densmore of The Doors
 Back Cover